Editor & Founder,
The Cheap Investor
Bill Mathews has been recognized as one of the foremost authorities in the country on investing in micro-cap and turnaround stocks. He founded The Cheap Investor more than 35 years ago in August, 1981, and it has been one of the most successful investment newsletters in the industry. Bill spent 15 years teaching business and investment courses at Triton College. He also taught securities analysis for the MBA program at the Keller Graduate School of Management.
Bill Mathews, founder and contributing editor to The Cheap Investor, selected Achillian Pharmaceuticals (ACHN) as a more speculative idea for 2019. The stock has risen 69%. Here's his latest update on this biotech firm.
After nearly 38 years, small cap, biotech expert Bill Mathews is retiring as editor of The Cheap Investor; we wish Bill and his wife Karen the very best for their coming years. Meanwhile, we leave our readers with some of Bill's parting comments on some of his favorite biotech ideas.
Applied Genetic Technologies (AGTC) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases, explains Bill Mathews, small cap expert and editor of The Cheap Investor.
Intrepid Potash (IPI) is a diversified mineral company that delivers potassium, magnesium, sulfur, salt and water products essential for customer success in agriculture, animal feed and the oil and gas industry, explains small cap expert Bill Mathews, editor of The Cheap Investor.